Navigation Links
Accumen Releases First FDA EUA COVID-19 Saliva Testing Kits
Date:8/3/2020

Accumen Inc. is helping healthcare get better, faster. Today the company announced a new partnership with medical equipment manufacturer, Spectrum Solutions, to provide COVID-19 saliva testing kits nationally.

“Accumen has been partnering with its clients to strengthen their laboratory supply chain for more than 10 years. Early in the COVID-19 crisis, we identified supply chain gaps and began coordinating resources to meet those evolving needs. As the crisis continued, we were able to provide critical testing supplies like nasopharyngeal (NP) swabs, media and personal protective equipment (PPE) for our clients, and we later made those resources available to other health systems and laboratories across the country to help increase testing efforts,” said Eric Jurinic, Accumen Vice President of Corporate Supply Chain.

Saliva testing for detecting COVID-19 first received FDA Emergency Use Authorization (EUA) in April. This authorization mandated saliva collection solely using Spectrum’s SDNA-1000 saliva collection device based on a trial with Rutgers University. The Spectrum saliva collection kit has been engineered to produce more accurate and sensitive test results, reduce sample collection errors, including for at-home self-collection, reduce labor required for collection and reduce use of valuable PPE.

Additionally, the SDNA-1000 delivers 100% neutralization of the live virus mitigating risk and the threat of unnecessary exposure. It can also preserve and stabilize viral RNA transcripts for transport in extreme and varying temperatures for more than 14 days and for up to one-year post collection in ambient storage.

Accumen offers full kit or saliva collection device only orders, as well as implementation support services. Full details and order contact information are available here: https://accumen.com/resources/collateral/covid-saliva-collection-overview/ .

Accumen continues to provide access to critical PPE for frontline workers produced by U.S.-based manufacturers. The Company’s COVID-19 Supply Chain Catalog with complete product details can be accessed at https://accumen.com/covid-19-resource-center/#supplychaincovidcatalog. Products include the aforementioned COVID-19 saliva testing kits, 3D-printed COVID-19 testing swabs, face shields and disposable masks, gowns, and gloves.

For healthcare providers and institutions that need immediate access to other COVID-19-related resources, Accumen provides laboratory, imaging, blood management rapid response tools and other strategic pandemic resources through its COVID-19 Resource Center at https://accumen.com/covid-19/#accumenresponsetools.

About Accumen Inc.
At Accumen, our focus is helping healthcare get better, faster. Accumen is a technology enabled organization that partners with hospital, health system, commercial laboratory, and payer clients, to provide strategic solutions and services that deliver sustainable performance improvements. Our offerings include lab and imaging transformation, consulting, supply chain optimization, lab outreach, 3D post-processing, patient blood management, test utilization, anemia management, and clinical data exchange. Accumen’s offerings enable our clients to achieve and exceed their cost, quality, and service targets, as well as deliver excellent patient care through evidence-based data and clinical decision support capabilities. Find out more at Accumen.com.

Disclaimer: Accumen has no authority, responsibility, or liability with respect to any clinical decisions made by – or in connection with – a provider’s laboratory, patient blood management, or other operations. Nothing herein and no aspect of any services provided by Accumen is intended – or shall be deemed – to subordinate, usurp, or otherwise diminish any providers’ sole authority and discretion with respect to all clinical decision-making for its patients.

About Spectrum Solutions and Spectrum DNA
Headquartered in Salt Lake City, Utah, Spectrum Solutions and its medical device and services division, Spectrum DNA, focus concentrated industry expertise on engineering innovative end-to-end solutions for both clinical diagnostic projects and commercial product plans. A single-source provider of on-site medical device manufacturing, custom packaging, kitting, and direct-to-consumer fulfillment. Our biosample collection devices, patented technologies, and dedicated services easily deliver measurable process optimization, unprecedented efficiency, and unmatched global scalability. For more information, please visit spectrumsolution.com/SDNA.

Accumen Contact
Kimberly MacDowell, Chief Marketing Officer
Phone: 858.621.3167 | Email: kmacdowell@accumen.com
2111 E Highland Ave, Ste 145 | Phoenix, AZ 85016

Accumen Media Contact
Lisa Osborne, CEO
Rana Healthcare Solutions
Phone: 206.992.5245 | Email: lisa@ranahealth.com

Spectrum Solutions Media Contact
Tim Rush
Springboard5
Phone: 801-208-1100 | Email: tim.rush@springboard5.com

Read the full story at https://www.prweb.com/releases/accumen_releases_first_fda_eua_covid_19_saliva_testing_kits/prweb17297894.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology news :

1. Plunging fish numbers linked to dam releases
2. Strax Rejuvenation Releases a New Radio Ad that is Getting a Lot of Attention from Listeners
3. Solar working group releases standard contracts
4. FASEB releases its FY 2015 funding report
5. FASEB releases updated NIH state factsheets
6. Neurotechnology Releases Latest Update to NCheck Biometric Time and Attendance Software
7. Digitus Biometrics Releases db Cabinet Sentry: A New Server Cabinet Access Control Platform
8. Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams
9. Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality
10. Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment
11. Daon Releases IdentityX v4.0
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2020)... , ... August 21, 2020 , ... ... Corporation has been published and is now available on the company’s global ... diffraction—serves the X-ray analysis community, presenting current news and crystallographic research. , ...
(Date:8/21/2020)... ... 20, 2020 , ... NDA Partners Chairman Carl Peck, ... with expertise in clinical trial planning and feasibility, regulatory inspection readiness, and clinical ... his career, Mr. Movahhed has helped design and manage oncology, neurology, cardiovascular, and ...
(Date:8/7/2020)... ... August 06, 2020 , ... Nine ... prestigious National STEM Scholar Program, a unique professional development program that provides advanced ... for middle school science teachers nationwide. , Created in partnership between the National ...
Breaking Biology News(10 mins):
(Date:7/1/2020)... ... June 29, 2020 , ... ... date growth of 40% in 2020, despite many obstacles created as a result ... to increase revenue for its partnered medical practices and medical manufacturers by expanding ...
(Date:7/1/2020)... ... June 30, 2020 , ... ... the launch of a new clinical diagnostics immuno-oncology service, TissueInsight . ... (TME). , “Flagship’s TissueInsight is a service that aids pathologists, oncologists, and ...
(Date:6/28/2020)... ... June 25, 2020 , ... With the COVID-19 pandemic impacting ... treatment. In an effort to better understand the cellular responses to COVID-19, the ... dataset portraying therapeutic compound effects from over 1,600 approved and referenced molecules on ...
(Date:6/28/2020)... ... June 26, 2020 , ... The Security ... announced its strong opposition to the recently introduced bicameral Facial Recognition and ... on most federal use of nearly all biometric and related image analytics technologies, ...
Breaking Biology Technology: